Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
42,018,768
-
Shares change
-
-83,620
-
Total reported value, excl. options
-
$375,641,780
-
Value change
-
-$24,086,836
-
Put/Call ratio
-
83%
-
Number of buys
-
50
-
Number of sells
-
-50
-
Price
-
$8.94
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2022
126 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q4 2022.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,018,768 shares
of 153,881,229 outstanding shares and own 27.31% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7,447,140 shares), RTW INVESTMENTS, LP (4,241,472 shares), EcoR1 Capital, LLC (3,560,700 shares), COWEN AND COMPANY, LLC (3,143,608 shares), BlackRock Inc. (2,545,618 shares), STATE STREET CORP (2,284,586 shares), Abingworth LLP (2,115,385 shares), VANGUARD GROUP INC (1,691,092 shares), MORGAN STANLEY (1,632,054 shares), and Polar Capital Holdings Plc (1,263,825 shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.